High expression of TARS is associated with poor prognosis of endometrial cancer
Figure 4.Overall survival grouped TARS expression. Overall survival group by GJB3 in (A) early stage, (B) advanced stage, (C) G1 and G2, (D) G3 and G4, (E) young, and (F) old.